Global Osteosarcoma Clinical Trials Research Trends- Analysis of Trial Phases, Markets, Recruitment, Trial Types, Enrolment, Intervention and Companies

Global Osteosarcoma Clinical Trials Research Trends- Analysis of Trial Phases, Markets, Recruitment, Trial Types, Enrolment, Intervention and Companies

  • August 2017 •
  • 120 pages •
  • Report ID: 5139474 •
  • Format: PDF
BMTP-11 shows potential for Ostepsarcoma therapy

Osteosarcoma clinical trials report from VPA Research provides comprehensive analysis and trends in global Osteosarcoma disease clinical trials. The research work analyzes the evolution of Osteosarcoma clinical trial trends across countries and regions.

The report focuses on drugs and therapies being evaluated for Osteosarcoma treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, phases, trial status and sponsor types.

Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner to enable readers quick access to Osteosarcoma clinical trials.

Scope of the Report-
- Number of Osteosarcoma clinical trials across regions- Asia and Oceania, Europe, Middle East Africa and Americas
- Trial information by Phase and Subjects recruited
- Trial information by status, type, sponsor type
- Drugs used for treatment of Osteosarcoma
- Both observational and interventional trials analyzed
- Success rates of trials are analyzed
- Trends in enrollment over the past ten years identified
- Leading sponsors of Osteosarcoma clinical trials worldwide are listed

Reasons to Buy
- Track competition and design competitive advantages
- Identify right partners to associate with for further research
- Evaluate potential opportunities available in further clinical trials of the disease
- Formulate business development strategies through success rates of clinical trials
- Identify quick markets for recruiting subjects based on trials count by each market

Executive Summary

Osteosarcoma is the most common sub-type of bone cancers. Also termed as osteogenic sarcoma, the disease can affect any bone in the body. However, it usually occurs in the metaphyses of long bones, usually around the knee.

Key Trends in Osteosarcoma Clinical Trials
- BMTP-11 shows potential for Ostepsarcoma therapy (It targets tumor and spares other organs)
- Valporic Acid in acceptable dose levels proved to be radiosensitizer for osteosarcoma in rats
Loading...

We are very sorry, but an error occurred.
Please contact [email protected] if the problem remains.